MedTrace Logo

Quantification of Diclofenac 2.32% (Voltaren) in Rinse Water After Different Application Methods

NCT06954181 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2026-06-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to quantify the amount of diclofenac in rinse water after application of the test product (Voltaren® Schmerzgel forte; 2.32 percent \[%\]) containing 2.32% Diclofenac-N-Ethylethanamin either by hand or using an applicator and subsequent washing and/or wiping.

Conditions

  • Healthy Participants

Interventions

DRUG

Voltaren® Schmerzgel forte; 2.32% (Test Product)

Voltaren® Schmerzgel forte; 2.32% containing 2.32% Diclofenac-N-Ethylethanamin.

Sponsors & Collaborators

  • HALEON

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-26
Primary Completion
2025-04-11
Completion
2025-04-11

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06954181 on ClinicalTrials.gov